BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33176727)

  • 1. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence.
    Vodstrcil LA; Plummer EL; Doyle M; Fairley CK; McGuiness C; Bateson D; Hocking JS; Law MG; Petoumenos K; Donovan B; Chow EPF; Bradshaw CS;
    BMC Infect Dis; 2020 Nov; 20(1):834. PubMed ID: 33176727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.
    Plummer EL; Vodstrcil LA; Doyle M; Danielewski JA; Murray GL; Fehler G; Fairley CK; Bulach DM; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
    mBio; 2021 Oct; 12(5):e0232321. PubMed ID: 34663095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study.
    Plummer EL; Vodstrcil LA; Danielewski JA; Murray GL; Fairley CK; Garland SM; Hocking JS; Tabrizi SN; Bradshaw CS
    PLoS One; 2018; 13(1):e0190199. PubMed ID: 29293559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
    Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
    PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis.
    Armstrong-Buisseret L; Brittain C; David M; Dean G; Griffiths F; Hepburn T; Jackson L; Kai J; Montgomery A; Roberts T; Thandi S; Ross JDC
    Trials; 2019 Nov; 20(1):648. PubMed ID: 31775859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial.
    Colli E; Landoni M; Parazzini F
    Genitourin Med; 1997 Aug; 73(4):267-70. PubMed ID: 9389947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use.
    Bradshaw CS; Vodstrcil LA; Hocking JS; Law M; Pirotta M; Garland SM; De Guingand D; Morton AN; Fairley CK
    Clin Infect Dis; 2013 Mar; 56(6):777-86. PubMed ID: 23243173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial.
    Anstey Watkins J; Ross JDC; Thandi S; Brittain C; Kai J; Griffiths F
    PLoS One; 2019; 14(11):e0224964. PubMed ID: 31730666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Male Sexual Partners of Women With Bacterial Vaginosis: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Schwebke JR; Lensing SY; Lee J; Muzny CA; Pontius A; Woznicki N; Aguin T; Sobel JD
    Clin Infect Dis; 2021 Aug; 73(3):e672-e679. PubMed ID: 33383580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT.
    Armstrong-Buisseret L; Brittain C; Kai J; David M; Anstey Watkins J; Ozolins M; Jackson L; Abdali Z; Hepburn T; Griffiths F; Montgomery A; Daniels J; Manley A; Dean G; Ross JD
    Health Technol Assess; 2022 Jan; 26(2):1-170. PubMed ID: 35057905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
    BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
    BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and Treatment of Recurrent Bacterial Vaginosis.
    Faught BM; Reyes S
    J Womens Health (Larchmt); 2019 Sep; 28(9):1218-1226. PubMed ID: 31403349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DEVA trial: protocol for a randomised controlled trial of dequalinium chloride versus usual care antibiotics for the treatment of bacterial vaginosis.
    Haydock R; Hepburn T; Ross J; Daniels J; Brittain C; Jackson L; Ozolins M; Wilson J
    Trials; 2022 Dec; 23(1):1040. PubMed ID: 36544202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.
    Bradshaw CS; Morton AN; Hocking J; Garland SM; Morris MB; Moss LM; Horvath LB; Kuzevska I; Fairley CK
    J Infect Dis; 2006 Jun; 193(11):1478-86. PubMed ID: 16652274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic treatment for the sexual partners of women with bacterial vaginosis.
    Amaya-Guio J; Viveros-Carreño DA; Sierra-Barrios EM; Martinez-Velasquez MY; Grillo-Ardila CF
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011701. PubMed ID: 27696372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.
    Zeron Mullins M; Trouton KM
    Trials; 2015 Jul; 16():315. PubMed ID: 26210791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial.
    Paavonen J; Mangioni C; Martin MA; Wajszczuk CP
    Obstet Gynecol; 2000 Aug; 96(2):256-60. PubMed ID: 10908773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriological epidemiology and treatment of bacterial vaginosis.
    Mikamo H; Kawazoe K; Izumi K; Ito K; Katoh N; Watanabe K; Ueno K; Tamaya T
    Chemotherapy; 1996; 42(1):78-84. PubMed ID: 8751270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.